Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling

[1]  V. Karantza,et al.  Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review , 2019, Breast Cancer Research.

[2]  D. Lu,et al.  Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[3]  W. Lu,et al.  Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis. , 2019, Developmental cell.

[4]  Jeffrey T. Chang,et al.  Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy , 2019, Cancers.

[5]  N. Borcherding,et al.  The clinical promise of immunotherapy in triple-negative breast cancer , 2018, Cancer management and research.

[6]  Qi Sun,et al.  Cancer-Associated Fibroblasts Correlate with Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer Patients , 2018, Journal of Cancer.

[7]  Jeffrey T. Chang,et al.  High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer , 2018, Nature Communications.

[8]  R. Chakrabarti,et al.  &Dgr;Np63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer , 2018, The Journal of clinical investigation.

[9]  Chien‐Hung Yeh,et al.  FBXW7: a critical tumor suppressor of human cancers , 2018, Molecular Cancer.

[10]  S. Adams,et al.  Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from here , 2018, Cancer.

[11]  K. Takeda,et al.  The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion , 2017, International journal of molecular sciences.

[12]  Yoshiyuki Suzuki,et al.  PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer , 2017, Cancer science.

[13]  Xiaosheng Wang,et al.  A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer , 2017, bioRxiv.

[14]  L. Dirix,et al.  Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study , 2017, Breast Cancer Research and Treatment.

[15]  J. Lunceford,et al.  IFN-&ggr;–related mRNA profile predicts clinical response to PD-1 blockade , 2017, The Journal of clinical investigation.

[16]  G. Di,et al.  Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance , 2017, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[17]  Amy M. Sitapati,et al.  NCCN Guidelines Insights: Breast Cancer, Version 1.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[18]  Lajos Pusztai,et al.  Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. Nishikawa,et al.  Roles of regulatory T cells in cancer immunity. , 2016, International immunology.

[20]  L. Hennighausen,et al.  Hierarchy within the mammary STAT5-driven Wap super-enhancer , 2016, Nature Genetics.

[21]  M. Hoenerhoff,et al.  Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases , 2016, PloS one.

[22]  D. Edwards,et al.  Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation , 2016, Nature Cell Biology.

[23]  I. Fernández,et al.  Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting , 2016, Clinical Medicine Insights. Oncology.

[24]  C. Hudis,et al.  NCCN Guidelines Insights Breast Cancer, Version 1.2016. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[25]  A. Azmi,et al.  Immune evasion in cancer: Mechanistic basis and therapeutic strategies. , 2015, Seminars in cancer biology.

[26]  J. Manson,et al.  An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis. , 2015, Cancer research.

[27]  Hamza Lasla,et al.  Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response , 2015, Breast Cancer Research.

[28]  Yuka Kanno,et al.  Mechanisms of Jak/STAT Signaling in Immunity and Disease , 2015, The Journal of Immunology.

[29]  E. Maher,et al.  VHL, the story of a tumour suppressor gene , 2014, Nature Reviews Cancer.

[30]  Zhongyu Yuan,et al.  High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis , 2014, OncoTargets and therapy.

[31]  Dino Amadori,et al.  ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signaling , 2014, Nature Cell Biology.

[32]  Q. Shen,et al.  Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies. , 2014, Cancer letters.

[33]  M. McNutt.  Cancer Immunotherapy , 2013, Science.

[34]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[35]  R. Vonderheide,et al.  Multicolor flow cytometric analysis of immune cell subsets in tumor-bearing mice. , 2013, Cold Spring Harbor protocols.

[36]  J. Markowitz,et al.  Myeloid-derived suppressor cells in breast cancer , 2013, Breast Cancer Research and Treatment.

[37]  E. Winer,et al.  Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network , 2012, Cancer.

[38]  Bruce G. Haffty,et al.  Elf5 Inhibits Epithelial Mesenchymal Transition in Mammary Gland Development and Breast Cancer Metastasis by Transcriptionally Repressing Snail2/slug Hhs Public Access Elf5 Knockdown in Epithelial-like T47d Breast Cancer Cells Induces Emt Elf5 Promotes Mesenchymal-epithelial Transition (met) in Mda- , 2022 .

[39]  Yibin Kang,et al.  Elf5 Regulates Mammary Gland Stem/Progenitor Cell Fate by Influencing Notch Signaling , 2012, Stem cells.

[40]  George Coukos,et al.  T-regulatory cells: key players in tumor immune escape and angiogenesis. , 2012, Cancer research.

[41]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[42]  A. Hoffmann,et al.  Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma , 2012, Nature Cell Biology.

[43]  P. Pfeffer,et al.  Elf5 regulation in the trophectoderm. , 2011, Developmental biology.

[44]  Mark T. W. Ebbert,et al.  Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.

[45]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[46]  Sean Davis,et al.  Interferon-γ links ultraviolet radiation to melanomagenesis in mice. , 2011, Nature.

[47]  P. Meltzer,et al.  Interferon-γ links UV to melanocyte activation and promotes melanomagenesis , 2010, Nature.

[48]  M. van Engeland,et al.  Characteristics of triple-negative breast cancer , 2010, Journal of Cancer Research and Clinical Oncology.

[49]  Z. Szallasi,et al.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.

[50]  A. Erbacher,et al.  Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2Rγnull Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Immature NK Cells , 2010, The Journal of Immunology.

[51]  Päivi Heikkilä,et al.  Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.

[52]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[53]  R. Chakrabarti,et al.  Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. , 2009, Developmental biology.

[54]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[55]  N. Simister,et al.  Activation of the JAK/STAT-1 Signaling Pathway by IFN-γ Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG1 , 2008, The Journal of Immunology.

[56]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[57]  S. Narod,et al.  Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.

[58]  L. Johannes,et al.  Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. , 2006, Molecular biology of the cell.

[59]  J. Visvader,et al.  Socs2 and elf5 mediate prolactin-induced mammary gland development. , 2006, Molecular endocrinology.

[60]  François Vaillant,et al.  Generation of a functional mammary gland from a single stem cell , 2006, Nature.

[61]  I. Kola,et al.  Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation , 2005, The EMBO journal.

[62]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[64]  H. Bern,et al.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. , 1959, Cancer research.

[65]  Yibin Kang,et al.  Transplantable mouse tumor models of breast cancer metastasis. , 2015, Methods in molecular biology.

[66]  S. Sinha,et al.  Generation and analysis of Elf5-LacZ mouse: unique and dynamic expression of Elf5 (ESE-2) in the inner root sheath of cycling hair follicles , 2007, Histochemistry and Cell Biology.